SL
Siren LLC Portfolio holdings
AUM
$1.93B
This Quarter Return
+73.94%
1 Year Return
+118.08%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$2.26B
AUM Growth
+$2.26B
(+13%)
Cap. Flow
+$139M
Cap. Flow
% of AUM
6.12%
Top 10 Holdings %
Top 10 Hldgs %
48.55%
Holding
132
New
22
Increased
22
Reduced
21
Closed
14
Top Buys
| 1 |
SEPN
Septerna, Inc. Common Stock
SEPN
|
$50.4M |
| 2 |
Madrigal Pharmaceuticals
MDGL
|
$38.9M |
| 3 |
Apogee Therapeutics
APGE
|
$33.9M |
| 4 |
NewAmsterdam Pharma
NAMS
|
$30.2M |
| 5 |
BCYC
Bicycle Therapeutics
BCYC
|
$25.8M |
Top Sells
| 1 |
Scholar Rock
SRRK
|
$86.8M |
| 2 |
LBPH
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
|
$30.1M |
| 3 |
Wave Life Sciences
WVE
|
$24.4M |
| 4 |
argenx
ARGX
|
$17.6M |
| 5 |
Biohaven
BHVN
|
$14.2M |
Sector Composition
| 1 | Healthcare | 92.88% |
| 2 | Technology | 3.51% |
| 3 | Communication Services | 1.85% |
| 4 | Consumer Discretionary | 0.74% |
| 5 | Real Estate | 0.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Spyre Therapeutics
SYRE
$996M
| $8.71M | 0.38% |
+374,000
| New | +$8.71M |
|
52
CrowdStrike
CRWD
$106B
| $8.21M | 0.36% |
24,000
-1,000
| -4% | -$342K |
|
53
Iovance Biotherapeutics
IOVA
$807M
| $8.18M | 0.36% |
1,106,040
| – | – |
|
54
Oric Pharmaceuticals
ORIC
$994M
| $8.13M | 0.36% |
1,007,575
| – | – |
|
55
Tango Therapeutics
TNGX
$747M
| $8.05M | 0.36% |
2,603,897
| – | – |
|
56
Amazon
AMZN
$2.44T
| $8.01M | 0.35% |
36,500
+1,750
| +5% | +$384K |
|
57
Rocket Pharmaceuticals
RCKT
$354M
| $7.54M | 0.33% |
+600,000
| New | +$7.54M |
|
58
IonQ
IONQ
$12.7B
| $7.1M | 0.31% |
170,000
-330,000
| -66% | -$13.8M |
|
59
IHS Holding
IHS
$2.43B
| $6.88M | 0.3% |
2,357,520
| – | – |
|
|
RAPP
60
Rapport Therapeutics
RAPP
$643M
| $6.82M | 0.3% |
384,197
| – | – |
|
61
NVIDIA
NVDA
$4.24T
| $6.57M | 0.29% |
48,932
| – | – |
|
62
ServiceNow
NOW
$190B
| $5.94M | 0.26% |
5,605
-1,895
| -25% | -$2.01M |
|
|
SLRN
63
DELISTED
ACELYRIN
SLRN
| $5.43M | 0.24% |
1,729,665
| – | – |
|
64
Pinduoduo
PDD
$171B
| $5.13M | 0.23% |
52,901
+12,500
| +31% | +$1.21M |
|
65
Gossamer Bio
GOSS
$562M
| $4.71M | 0.21% |
5,208,968
-8,072,642
| -61% | -$7.3M |
|
66
Dynatrace
DT
$15.3B
| $4.5M | 0.2% |
82,729
| – | – |
|
67
Boeing
BA
$177B
| $4.43M | 0.2% |
+25,000
| New | +$4.43M |
|
68
New Oriental
EDU
$7.85B
| $4.4M | 0.19% |
68,500
+30,000
| +78% | +$1.93M |
|
69
Datadog
DDOG
$47.7B
| $4.35M | 0.19% |
30,425
-2,500
| -8% | -$357K |
|
70
ProQR Therapeutics
PRQR
$237M
| $4.17M | 0.18% |
+1,575,000
| New | +$4.17M |
|
71
Lexeo Therapeutics
LXEO
$259M
| $3.97M | 0.18% |
603,435
| – | – |
|
72
Adobe
ADBE
$151B
| $3.91M | 0.17% |
8,798
+7,798
| +780% | +$3.47M |
|
73
Phathom Pharmaceuticals
PHAT
$864M
| $3.74M | 0.17% |
460,753
| – | – |
|
74
Instil Bio
TIL
$182M
| $3.67M | 0.16% |
192,433
| – | – |
|
75
JFrog
FROG
$5.76B
| $3.53M | 0.16% |
120,116
+59,116
| +97% | +$1.74M |
|